8. Profit After Tax (PAT) Rs. 83 Crs 167%YoY. 9. 92.3% GMV comes from B2C business . 10. 88.8% transactions are done by B2C customers.
Business Update
1. Company’s employee expenses for Q3FY22 as a % of GBR stood at 0.5% compared to 0.6% for the same quarter last year. For 9MFY22 employee expenses as a % of GBR stood at 0.7% as compared to 1.2% for 9MFY21
2. With focused marketing & sales promotion expenses we have been able to increase our market share.
Marketing expenses stood at around 0.9% of GBR for 9MFY22 as compared to 0.8% of GBR in 9MFY21.
10. Other expenses as a % of GBR were consistent at 1.2% in 9MFY22 with 1.2% in 9MFY21.
11. Air Segments for the quarter were up by 49% and for 9MFY22 were up by 87%
12. Hotel nights booking in Q3FY22 & 9MFY22 were up by 144% & 357% respectively. We have achieved a new height in our hotel nights booking segment in 9MFY22 and are confident of future growth in this segment, with our competitive pricing & video offerings across hotels.
13. Recovery in travel & tourism sector has enabled high growth in bookings across segments.
14. The company acquired Spree Hospitality,a 1200 room-keys hospitality management company in order to expand presence in the hotel and holiday segment
Company paid 18.25Cr for this deal
15. Also Acquired Traviate which will add a new revenue stream and further strengthen the company’s offerings and portfolio in the B2B hotel and holiday space.
16. Traviate is India’s first B2B technology-driven travel marketplace that enables the travel ecosystem to connect and transact efficiently.
17. Company acquired Yolobus
By acquiring the brand name and technology of ‘Yolobus’, a premium intercity mobility platform, the company's plan is to grow presence in the non-air segment.
18. Company also decided First-ever brand ambassadors for the nationwide brand campaign, a 2 year contract.
Varun Sharma and Vijay Raaz were appointed as first-ever brand ambassadors as part of a nationwide brand initiative
19. Company declared total interim dividend payout of Rs. 32.59 Cr ; Announced one in May’21 (100%) and second in November (50%).
Future Outlook
1. Company also plans to acquire 2 more companies in coming quarters, with a vision of creating an ecosystem on the travel side and become a market leader in the coming 3-5 years.
2. Company expects its non-air revenue to double every year.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
1. Revenue for the quarter is ₹238.4 Cr (2.9% decline YoY). EBITDA for the quarter was ₹34.2 Cr (26.8% decline YoY) with an EBITDA margin of 14.3%.
2. They are facing supply chain issues due to raw material volatility and high logistics cost. They also benefited in the last few quarters due to raw material hedging for key ingredients, but those contracts expired in Q2 which caused a decline in margins.
They are holding higher inventory in case of possible future disruptions. 3. Currently profitability is low due to costs associated with commercialization on Unit 3. They expect more volumes from Unit 3 in the coming quarters.
1. The company has announced a buyback of ₹352 Cr including taxes. Including dividend, total payout to the shareholder for the financial year is at ₹434 Cr
2. Emerging Markets business (Branded Generics) - Spread across Asia and Africa and contributes 41% of revenues. Exports to these markets were ₹361 Cr (26% growth YoY).
Sales to Asia were ₹194 Cr (1% decline YoY). Sales to Africa were ₹167 Cr (87% growth YoY) however growth looks higher due to low base effect.
3. US Generic Business - Contributed 22% of revenues. Sales were ₹166 Cr(3% growth YoY).
1. The revenue for Q3FY22 grew by 22% QoQ to ₹255 Cr from ₹208.8 Cr in the previous quarter.
2. Gross margins stood at 37% in Q3FY22 compared to 40.6% in previous quarter, degrowth of (-362 bp)
3. 53.05% contribution of revenue from exports and 46.9% from domestic markets
4. Top 10 products contributed 65%+ revenues in 9MFY22
5. The contracts with Nippon Kayaku and a japanese company are performing well, the clients are satisfied with the product quality and high demand for molecules is anticipated